EXEL
EXEL
NASDAQ · Biotechnology

Exelixis Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$48.16
+1.95 (+4.22%)
As of May 9, 1:09 AM ET ·
Analyst Consensus
Buy
27
Analysts
High
Coverage
Buy 15 56%
Hold 11 41%
Sell 1 4%
Price Target
Analyst Price Target +141.1% upside
Low Target $78.53
Average Target $116.10
High Target $123.77
Current Price $48.16
Current
$48.16
Target
$116.10
$78.53 $116.10 avg $123.77
Scenario Analysis
Bear Case
$78.53
63.1%
Low target
Base Case
$116.10
+141.1%
Avg target
Bull Case
$123.77
+157.0%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$49.62
-2.9% from high
52-Week Low
$33.76
+42.7% from low
50-Day SMA
$43.59
+10.5% vs SMA
200-Day SMA
$41.49
+16.1% vs SMA
RSI (14)
62.0
Neutral
Target vs 52W High
$116.10
+134.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%